Analysis of aggregates in naked mRNA and mRNA extracted from lipid nanoparticles in a mRNA vaccine against COVID-19

Key Points

• The aim is to analyze aggregates in naked mRNA versus mRNA from lipid nanoparticles in a COVID-19 vaccine.
• Analyze components of mRNA before and after extraction from lipid nanoparticles.
• Examine aggregate formation in different types of mRNA samples.
• Present findings at the International Symposium on Immunobiologicals.
• Identification of differences in aggregate presence between naked mRNA and lipid nanoparticle-extracted mRNA.
• Insights into mRNA stability and interaction with lipid nanoparticles for better vaccine efficacy.